S1pping fire: Sphingosine-1-phosphate signaling as an emerging target in inflammatory bowel disease and colitis-associated cancer

References

• OdzeRDiagnostic problems and advances in inflammatory bowel diseaseMod Pathol200316434735812692200
   PubMed Web of Science ®Google Scholar
• UllmanTAItzkowitzSHIntestinal inflammation and cancerGastroenterology201114061807181621530747
   PubMed Web of Science ®Google Scholar
• BosaniMArdizzoneSPorroGBBiologic targeting in the treatment of inflammatory bowel diseasesBiologics20093779719707398
   PubMedGoogle Scholar
• NeurathMFCytokines in inflammatory bowel diseaseNat Rev Immunol201414532934224751956
   PubMed Web of Science ®Google Scholar
• SylvesterFAGordonCMThayuMReport of the CCFA pediatric bone, growth and muscle health workshop, New York City, November 11–12, 2011, with updatesInflamm Bowel Dis201319132919292623974992
   PubMed Web of Science ®Google Scholar
• BaumgartDCSandbornWJCrohn’s diseaseLancet201238098531590160522914295
   PubMed Web of Science ®Google Scholar
• OrdásIEckmannLTalaminiMBaumgartDCSandbornWJUlcerative colitisLancet201238098531606161922914296
   PubMed Web of Science ®Google Scholar
• BlumbergRSInflammation in the intestinal tract: pathogenesis and treatmentDig Dis200927445546419897960
   PubMed Web of Science ®Google Scholar
• AbrahamCMedzhitovRInteractions between the host innate immune system and microbes in inflammatory bowel diseaseGastroenterology201114061729173721530739
   PubMed Web of Science ®Google Scholar
• KaserABlumbergRSAdaptive immunity in inflammatory bowel disease: state of the artCurr Opin Gastroenterol200824445546118622159
   PubMed Web of Science ®Google Scholar
• IskandarHNCiorbaMABiomarkers in inflammatory bowel disease: current practices and recent advancesTransl Res2012159431332522424434
   PubMed Web of Science ®Google Scholar
• ChristophiGPRongRHoltzapplePGMassaPTLandasSKImmune markers and differential signaling networks in ulcerative colitis and Crohn’s diseaseInflamm Bowel Dis201218122342235622467146
   PubMed Web of Science ®Google Scholar
• BiswasAPetnicki-OcwiejaTKobayashiKSNod2: a key regulator linking microbiota to intestinal mucosal immunityJ Mol Med (Berl)2012901152421861185
   PubMed Web of Science ®Google Scholar
• BonifaceKBlomBLiuYJde Waal MalefytRFrom interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisitedImmunol Rev200822613214619161421
   PubMed Web of Science ®Google Scholar
• DubinskyMCWangDPicornellYWestern Regional Research Alliance for Pediatric IBDIL-23 receptor (IL-23R) gene protects against pediatric Crohn’s diseaseInflamm Bowel Dis200713551151517309073
   PubMed Web of Science ®Google Scholar
• NaserSAArceMKhajaARole of ATG16L, NOD2 and IL23R in Crohn’s disease pathogenesisWorld J Gastroenterol201218541242422346247
   PubMed Web of Science ®Google Scholar
• MaloyKJKullbergMCIL-23 and Th17 cytokines in intestinal homeostasisMucosal Immunol20081533934919079198
   PubMed Web of Science ®Google Scholar
• NobleCLAbbasARLeesCWCharacterization of intestinal gene expression profiles in Crohn’s disease by genome-wide microarray analysisInflamm Bowel Dis201016101717172820848455
   PubMed Web of Science ®Google Scholar
• McGovernDPGardetATörkvistLNIDDK IBD Genetics ConsortiumGenome-wide association identifies multiple ulcerative colitis susceptibility lociNat Genet201042433233720228799
   PubMed Web of Science ®Google Scholar
• GrivennikovSKarinETerzicJIL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancerCancer Cell200915210311319185845
   PubMed Web of Science ®Google Scholar
• FestenEASzperlAMWeersmaRKWijmengaCWapenaarMCInflammatory bowel disease and celiac disease: overlaps in the pathology and genetics, and their potential drug targetsEndocr Metab Immune Disord Drug Targets20099219921819519468
   PubMedGoogle Scholar
• ErdmanSEPoutahidisTRoles for inflammation and regulatory T cells in colon cancerToxicol Pathol2010381768720019355
   PubMed Web of Science ®Google Scholar
• HayakawaYMaedaSNakagawaHEffectiveness of IkappaB kinase inhibitors in murine colitis-associated tumorigenesisJ Gastroenterol200944993594319557302
   PubMed Web of Science ®Google Scholar
• BrombergJWangTCInflammation and cancer: IL-6 and STAT3 complete the linkCancer Cell2009152798019185839
   PubMed Web of Science ®Google Scholar
• AaronsonDSHorvathCMA road map for those who don’t know JAK-STATScience200229655731653165512040185
   PubMed Web of Science ®Google Scholar
• GrivennikovSIKarinMDangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancerCytokine Growth Factor Rev2010211111920018552
   PubMed Web of Science ®Google Scholar
• ScaldaferriFCorrealeCGasbarriniADaneseSMolecular signaling blockade as a new approach to inhibit leukocyte-endothelial interactions for inflammatory bowel disease treatmentCell Adh Migr20093329629919571660
   PubMed Web of Science ®Google Scholar
• DaneseSRole of the vascular and lymphatic endothelium in the pathogenesis of inflammatory bowel disease: ‘brothers in arms’Gut2011607998100821212253
   PubMed Web of Science ®Google Scholar
• FyrstHSabaJDAn update on sphingosine-1-phosphate and other sphingolipid mediatorsNat Chem Biol20106748949720559316
   PubMed Web of Science ®Google Scholar
• SpiegelSMilstienSThe outs and ins of sphingosine-1-phosphate in immunityNat Rev Immunol201111640341521546914
   PubMed Web of Science ®Google Scholar
• RiveraJProiaRLOliveraAThe alliance of sphingosine-1-phosphate and its receptors in immunityNat Rev Immunol200881075376318787560
   PubMed Web of Science ®Google Scholar
• LeeHDengJKujawskiMSTAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumorsNat Med201016121421142821102457
   PubMed Web of Science ®Google Scholar
• SlatteryMLLundgreenAKadlubarSABondurantKLWolffRKJAK/STAT/SOCS-signaling pathway and colon and rectal cancerMol Carcinog201352215516622121102
   PubMed Web of Science ®Google Scholar
• CorvinusFMOrthCMorigglRPersistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growthNeoplasia20057654555516036105
   PubMed Web of Science ®Google Scholar
• LinQLaiRChirieacLRConstitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cellsAm J Pathol2005167496998016192633
   PubMed Web of Science ®Google Scholar
• SantandreuFMValleAOliverJRocaPResveratrol potentiates the cytotoxic oxidative stress induced by chemotherapy in human colon cancer cellsCell Physiol Biochem201128221922821865729
   PubMedGoogle Scholar
• WangZJinHXuRMeiQFanDTriptolide downregulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progressionExp Mol Med2009411071772719561401
   PubMed Web of Science ®Google Scholar
• LiYde HaarCChenMDisease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesisGut201059222723519926618
   PubMed Web of Science ®Google Scholar
• OskouianBSabaJSphingosine-1-phosphate metabolism and intestinal tumorigenesis: lipid signaling strikes againCell Cycle20076552252717361098
   PubMed Web of Science ®Google Scholar
• FuruyaHShimizuYKawamoriTSphingolipids in cancerCancer Metastasis Rev2011303–456757622005951
   PubMed Web of Science ®Google Scholar
• AlvarezSEHarikumarKBHaitNCSphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2Nature201046573011084108820577214
   PubMed Web of Science ®Google Scholar
• HaitNCAllegoodJMaceykaMRegulation of histone acetylation in the nucleus by sphingosine-1-phosphateScience200932559451254125719729656
   PubMed Web of Science ®Google Scholar
• MandalaSMSphingosine-1-phosphate phosphatasesProstaglandins2001641–414315611331102
   PubMed Web of Science ®Google Scholar
• AguilarASabaJDTruth and consequences of sphingosine-1-phosphate lyaseAdv Biol Regul2012521173021946005
   PubMedGoogle Scholar
• SabaJDNaraFBielawskaAGarrettSHannunYAThe BST1 gene of Saccharomyces cerevisiae is the sphingosine-1-phosphate lyaseJ Biol Chem19972724226087260909334171
   PubMed Web of Science ®Google Scholar
• OskouianBSooriyakumaranPBorowskyADSphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancerProc Natl Acad Sci U S A200610346173841738917090686
   PubMed Web of Science ®Google Scholar
• KohnoMMomoiMOoMLIntracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferationMol Cell Biol200626197211722316980623
   PubMed Web of Science ®Google Scholar
• LiangJNagahashiMKimEYSphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancerCancer Cell201323110712023273921
   PubMed Web of Science ®Google Scholar
• DuanRDPhysiological functions and clinical implications of sphin-golipids in the gutJ Dig Dis2011122607021401891
   PubMed Web of Science ®Google Scholar
• SkiecevicieneJKiudelisGEllinghausEReplication study of ulcerative colitis risk loci in a Lithuanian-Latvian case-control sampleInflamm Bowel Dis201319112349235523974994
   PubMed Web of Science ®Google Scholar
• MatloubianMLoCGCinamonGLymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1Nature2004427697235536014737169
   PubMed Web of Science ®Google Scholar
• LoCGXuYProiaRLCysterJGCyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transitJ Exp Med2005201229130115657295
   PubMed Web of Science ®Google Scholar
• SchwabSRPereiraJPMatloubianMXuYHuangYCysterJGLymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradientsScience200530957411735173916151014
   PubMed Web of Science ®Google Scholar
• VogelPDonovielMSReadRIncomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesionsPLoS One200941e411219119317
   PubMed Web of Science ®Google Scholar
• BréartBRamos-PerezWDMendozaALipid phosphate phosphatase 3 enables efficient thymic egressJ Exp Med201120861267127821576386
   PubMed Web of Science ®Google Scholar
• KapposLAntelJComiGFTY720 D2201 Study GroupOral fingolimod (FTY720) for relapsing multiple sclerosisN Engl J Med2006355111124114016971719
   PubMed Web of Science ®Google Scholar
• KapposLRadueEWO’ConnorPFREEDOMS Study GroupA placebo-controlled trial of oral fingolimod in relapsing multiple sclerosisN Engl J Med2010362538740120089952
   PubMed Web of Science ®Google Scholar
• CohenJABarkhofFComiGTRANSFORMS Study GroupOral fingolimod or intramuscular interferon for relapsing multiple sclerosisN Engl J Med2010362540241520089954
   PubMed Web of Science ®Google Scholar
• ComiGO’ConnorPMontalbanXFTY720D2201 Study GroupPhase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year resultsMult Scler201016219720720028707
   PubMed Web of Science ®Google Scholar
• WangFOkamotoYInokiISphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient miceJ Clin Invest2010120113979399520978351
   PubMed Web of Science ®Google Scholar
• GarrisCSWuLAcharyaSDefective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammationNat Immunol201314111166117224076635
   PubMed Web of Science ®Google Scholar
• NixonGFSphingolipids in inflammation: pathological implications and potential therapeutic targetsBr J Pharmacol2009158498299319563535
   PubMed Web of Science ®Google Scholar
• DuanRDNilssonAMetabolism of sphingolipids in the gut and its relation to inflammation and cancer developmentProg Lipid Res2009481627219027789
   PubMed Web of Science ®Google Scholar
• SooIMadsenKLTejparQVSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammationCan J Gastroenterol200822323724218354751
   PubMed Web of Science ®Google Scholar
• MazzeiJCZhouHBrayfieldBPHontecillasRBassaganya-RieraJSchmelzEMSuppression of intestinal inflammation and inflammation-driven colon cancer in mice by dietary sphingomyelin: importance of peroxisome proliferator-activated receptor γ expressionJ Nutr Biochem201122121160117121295961
   PubMed Web of Science ®Google Scholar
• DeguchiYAndohAYagiYThe S1P receptor modulator FTY720 prevents the development of experimental colitis in miceOncol Rep200616469970316969482
   PubMed Web of Science ®Google Scholar
• SanadaYMizushimaTKaiYTherapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitisPLoS One201169e2393321931623
   PubMed Web of Science ®Google Scholar
• MizushimaTItoTKishiDTherapeutic effects of a new lymphocyte homing reagent FTY720 in interleukin-10 gene-deficient mice with colitisInflamm Bowel Dis200410318219215290910
   PubMed Web of Science ®Google Scholar
• SongJMatsudaCKaiYA novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient miceJ Pharmacol Exp Ther2008324127628317898319
   PubMed Web of Science ®Google Scholar
• FussIJNeurathMBoirivantMDisparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5J Immunol19961573126112708757634
   PubMed Web of Science ®Google Scholar
• StroberWFussIJProinflammatory cytokines in the pathogenesis of inflammatory bowel diseasesGastroenterology201114061756176721530742
   PubMed Web of Science ®Google Scholar
• FussIJHellerFBoirivantMNonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitisJ Clin Invest2004113101490149715146247
   PubMed Web of Science ®Google Scholar
• DanielCSartoryNAZahnNFTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functionsMol Immunol200744133305331617475330
   PubMed Web of Science ®Google Scholar
• DanielCSartoryNZahnNGeisslingerGRadekeHHSteinJMFTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cellsJ Immunol200717842458246817277153
   PubMed Web of Science ®Google Scholar
• SniderAJKawamoriTBradshawSGA role for sphingosine kinase 1 in dextran sulfate sodium-induced colitisFASEB J200923114315218815359
   PubMed Web of Science ®Google Scholar
• MainesLWFitzpatrickLRFrenchKJSuppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinaseDig Dis Sci2008534997101218058233
   PubMed Web of Science ®Google Scholar
• BorowskyADBandhuvulaPKumarASphingosine-1-phosphate lyase expression in embryonic and adult murine tissuesNatl Acad Sci USA2006103461738417389
   Google Scholar
• OskouianB1SooriyakumaranPBorowskyADSphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancerJ Lipid Res20125391920193122781001
   PubMed Web of Science ®Google Scholar
• SelhubJByunALiuZMasonJBBronsonRTCrottJWDietary vitamin B6 intake modulates colonic inflammation in the IL10−/− model of inflammatory bowel diseaseJ Nutr Biochem201324122138214324183308
   PubMed Web of Science ®Google Scholar
• PaughBSBryanLPaughSWInterleukin-1 regulates the expression of sphingosine kinase 1 in glioblastoma cellsJ Biol Chem200928463408341719074142
   PubMed Web of Science ®Google Scholar
• YamaguchiKLantowskiADannenbergAJSubbaramaiahKHistone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2J Biol Chem200528038325693257715994313
   PubMed Web of Science ®Google Scholar
• AtreyaIAtreyaRNeurathMFNF-kappaB in inflammatory bowel diseaseJ Intern Med2008263659159618479258
   PubMed Web of Science ®Google Scholar
• KarinMNF-kappaB as a critical link between inflammation and cancerCold Spring Harb Perspect Biol200915a00014120066113
   PubMed Web of Science ®Google Scholar
• XiaoWHodgeDRWangLYangXZhangXFarrarWLNF-kappaB activates IL-6 expression through cooperation with c-Jun and IL6-AP1 site, but is independent of its IL6-NFkappaB regulatory site in autocrine human multiple myeloma cellsCancer Biol Ther20043101007101715467434
   PubMed Web of Science ®Google Scholar
• BrinkmannVFTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous systemBr J Pharmacol200915851173118219814729
   PubMed Web of Science ®Google Scholar
• VesseyDAKelleyMZhangJLiLTaoRKarlinerJSDimethylsphingosine and FTY720 inhibit the SK1 form but activate the SK2 form of sphingosine kinase from rat heartJ Biochem Mol Toxicol200721527327917912702
   PubMed Web of Science ®Google Scholar
• LimKGTonelliFLiZFTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cellsJ Biol Chem201128621186331864021464128
   PubMed Web of Science ®Google Scholar
• VesperHSchmelzEMNikolova-KarakashianMNDillehayDLLynchDVMerrillAHJrSphingolipids in food and the emerging importance of sphingolipids to nutritionJ Nutr199912971239125010395583
   PubMed Web of Science ®Google Scholar
• ThakerAIShakerARaoMSCiorbaMAModeling colitis-associated cancer with azoxymethane (AOM) and dextran sulfate sodium (DSS)J Vis Exp201267
   Web of Science ®Google Scholar
• SantiagoCPagánBIsidroAAAppleyardCBProlonged chronic inflammation progresses to dysplasia in a novel rat model of colitis-associated colon cancerCancer Res20076722107661077318006820
   PubMed Web of Science ®Google Scholar
• HamizaOORehmanMUTahirMAmelioration of 1,2 dimethylhydrazine (DMH) induced colon oxidative stress, inflammation and tumor promotion response by tannic acid in Wistar ratsAsian Pac J Cancer Prev20121394393440223167349
   PubMedGoogle Scholar
• DillehayDLWebbSKSchmelzEMMerrillAHJrDietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 miceJ Nutr199412456156208169652
   PubMed Web of Science ®Google Scholar
• SymolonHSchmelzEMDillehayDLMerrillAHJrDietary soy sphingolipids suppress tumorigenesis and gene expression in 1,2-dimethylhydrazine-treated CF1 mice and ApcMin/+ miceJ Nutr200413451157116115113963
   PubMed Web of Science ®Google Scholar
• MazzeiJCZhouHBrayfieldBPHontecillasRBassaganya-RieraJSchmelzEMSuppression of intestinal inflammation and inflammation-driven colon cancer in mice by dietary sphingomyelin: importance of peroxisome proliferator-activated receptor γ expressionJ Nutr Biochem201122121160117121295961
   PubMed Web of Science ®Google Scholar
• FischbeckALeuchtKFrey-WagnerISphingomyelin induces cathepsin D-mediated apoptosis in intestinal epithelial cells and increases inflammation in DSS colitisGut2011601556521076125
   PubMed Web of Science ®Google Scholar
• FyrstHOskouianBBandhuvulaPNatural sphingadienes inhibit Akt-dependent signaling and prevent intestinal tumorigenesisCancer Res200969249457946419934323
   PubMed Web of Science ®Google Scholar
• KumarAPanduranganAKLuFChemopreventive sphingadienes downregulate Wnt signaling via a PP2A/Akt/GSK3β pathway in colon cancerCarcinogenesis20123391726173522581840
   PubMed Web of Science ®Google Scholar
• MontroseDCScherlEJBosworthBPS1P. localizes to the colonic vasculature in ulcerative colitis and maintains blood vessel integrityJ Lipid Res201354384385123296878
   PubMed Web of Science ®Google Scholar
• MurphyCTHallLJHurleyGThe sphingosine-1-phosphate analogue FTY720 impairs mucosal immunity and clearance of the enteric pathogen Citrobacter rodentiumInfect Immun20128082712272322615252
   PubMed Web of Science ®Google Scholar
• SamyETMeyerCACaplaziPCutting edge: Modulation of intestinal autoimmunity and IL-2 signaling by sphingosine kinase 2 independent of sphingosine 1-phosphateJ Immunol200717995644564817947634
   PubMed Web of Science ®Google Scholar